Ketoconazole in the treatment of cutaneous leishmaniasis in Kuwait.
Alsaleh
Q A
QA
Department of Dermatology, Al-Sabah Hospital, Kuwait.
Dvorak
R
R
Nanda
A
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007654:Ketoconazole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007730:Kuwait; D016773:Leishmaniasis, Cutaneous / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D000935:Antifungal Agents; D007654:Ketoconazole